Related content

Antitumour activity of the novel immune modulator 5,6-dimethylxanthenone-4-acetic acid (DMXAA) in mice lacking the interferon-gamma receptor

By Pang J.-H.   Cao Z.   Joseph W.R.   Baguley B.C.   Ching L.-M.  

European Journal of Cancer, Vol. 34, Iss. 8, 1998-07 ,pp. : 1282-1289

Elsevier

Access to resources Recommend Favorite

Potentiation of the anti-tumour effect of hyperthermia by combining with the vascular targeting agent 5,6-dimethylxanthenone-4-acetic acid

By Murata R.   Overgaard J.   Horsman M. R.  

International Journal of Hyperthermia, Vol. 17, Iss. 6, 2001-11 ,pp. : 508-519

Informa Healthcare

Access to resources Recommend Favorite

In vitro and in vivo kinetic interactions of the antitumour agent 5,6-dimethylxanthenone-4-acetic acid with thalidomide and diclofenac

By Zhou Shufeng   Paxton James W.   Kestell Philip   Tingle Malcolm D.   Ching Lai-Ming  

Cancer Chemotherapy and Pharmacology, Vol. 47, Iss. 4, 2001-04 ,pp. : 319-326

Springer Publishing Company

Access to resources Recommend Favorite

The effect of combretastatin A4 disodium phosphate and 5,6-dimethylxanthenone-4-acetic acid on water diffusion and blood perfusion in tumours

By Chen Gang   Horsman Michael   Pedersen Michael   Pang Qi   Stødkilde-jørgensen Hans  

Acta Oncologica, Vol. 47, Iss. 6, 2008-08 ,pp. : 1071-1076

Informa Healthcare

Access to resources Recommend Favorite

The antitumour agent 5,6-dimethylxanthenone-4-acetic acid acts in vitro on human mononuclear cells as a co-stimulator with other inducers of tumour necrosis factor

By Philpott M.   Ching L.-M.   Baguley B.C.  

European Journal of Cancer, Vol. 37, Iss. 15, 2001-10 ,pp. : 1930-1937

Elsevier

Access to resources Recommend Favorite